Studies found that for IBD patients during the active period, the production of IL-1β and IL-18 and the activity of caspase-1 increase, thereby mediating the occurrence of intestinal cell apoptosis (Qi et al., 2021). This evidence concerns the gene IL1B and irritable bowel syndrome.